Open AccessEconomic Burden of Treatment-Resistant Depression among Adults with Chronic Non-Cancer Pain Conditions and Major Depressive Disorder in the US
Author(s) -
Drishti Shah,
Lindsay Allen,
Zheng Wang,
Suresh Madhavan,
Wenhui Wei,
Traci LeMasters,
Usha Sambamoorthi
Publication year - 2021
Publication title -
pharmacoeconomics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.809
H-Index - 100
eISSN - 1179-2027
pISSN - 1170-7690
DOI - 10.1007/s40273-021-01029-2
Subject(s) - treatment resistant depression , major depressive disorder , depression (economics) , medicine , cohort , incidence (geometry) , psychiatry , mood , optics , economics , macroeconomics , physics
Major depressive disorder (MDD) and chronic non-cancer pain conditions (CNPC) often co-occur and exacerbate one another. Treatment-resistant depression (TRD) in adults with CNPC can amplify the economic burden. This study examined the impact of TRD on direct total and MDD-related healthcare resource utilization (HRU) and costs among commercially insured patients with CNPC and MDD in the US.